Rising Hope Counseling Services, Llc | |
153 Old Plainfield Pike Foster RI 02825-1513 | |
(401) 618-4494 | |
Not Available |
Full Name | Rising Hope Counseling Services, Llc |
---|---|
Speciality | Counselor - Mental Health |
Location | 153 Old Plainfield Pike, Foster, Rhode Island |
Authorized Official Name and Position | Sarah Lafontaine (OWNER) |
Authorized Official Contact | 4016184494 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Rising Hope Counseling Services, Llc 153 Old Plainfield Pike Foster RI 02825-1513 Ph: () - | Rising Hope Counseling Services, Llc 153 Old Plainfield Pike Foster RI 02825-1513 Ph: (401) 618-4494 |
NPI Number | 1841863057 |
---|---|
Provider Enumeration Date | 07/24/2021 |
Last Update Date | 07/24/2021 |
Certification Date | 07/24/2021 |
Identifier | Type | State | Issuer |
---|---|---|---|
1841863057 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
News Archive
A new discovery by Michigan State University scientists suggests that a common medication used to treat glaucoma could also be used to treat tuberculosis, even the drug-resistant kind.
Many different countries have a tea culture, and Japanese Matcha tea is growing in popularity around the world. In Japan, Matcha has a long history of being used for various medicinal purposes. It has been suspected to have various beneficial effects to health, but relatively little scientific evidence supported that claim.
"Uninsured patients with traumatic injuries, such as car crashes, falls and gunshot wounds, were almost twice as likely to die in the hospital as similarly injured patients with health insurance, according to a troubling new study," The Associated Press reports. "The findings by Harvard University researchers surprised doctors and health experts who have believed emergency room care was equitable."
Only 53 percent of newly diagnosed breast cancer patients who were at high risk of carrying a BRCA 1 or BRCA 2 mutation - based on age, diagnosis, and family history of breast or ovarian cancer - reported that their doctors urged them to be tested for the genes, according to a research team from the Perelman School of Medicine at the University of Pennsylvania.
› Verified 8 days ago